What is DVA stock price today?

DVA (Davita Inc) stock is trading at $156.30 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is DVA stock going up or down today?

DVA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy DVA stock now?

The decision to buy DVA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is DVA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for DVA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is DVA stock overvalued or undervalued?

DVA currently trades at a P/E ratio of 16.45 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if DVA is fairly priced.

What is DVA's P/E ratio?

DVA has a price-to-earnings (P/E) ratio of 16.45, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is DVA's market cap?

DVA (Davita Inc) has a market capitalization of $10.45 billion, making it a mid-cap stock.

What is DVA's price to book ratio?

DVA trades at a price-to-book (P/B) ratio of 21.63, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does DVA pay dividends?

DVA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is DVA's dividend yield?

DVA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is DVA stock a good long-term investment?

DVA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is DVA's revenue growth rate?

DVA has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, DVA is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in DVA?

Key risks for DVA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does DVA compare to its competitors?

Compare DVA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize DVA's performance and positioning.

What is DVA's stock price target for 2026?

Our AI model provides price targets for DVA based on fundamental analysis: Bull case $203.19 (+30%), Base case $179.75 (+15%), Bear case $140.67 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about DVA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for DVA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is DVA's next earnings report?

DVA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

DVA - Davita Inc

NYSE * Health Care * Health Care Providers & Services

$156.30

+$3.76 (+2.46%)

About Davita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DVA Key Statistics

Market Cap

$10.45B

P/E Ratio

16.45

P/B Ratio

21.63

EPS

$9.50

Revenue Growth

+0.1%

Profit Margin

0.1%

Employees

78,000

How DVA Compares to Peers

DVA has the lowest P/E ratio in Health Care Providers & Services, suggesting it may be the most undervalued

DVA is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
DVA(This stock)	$10.45B	16.5	0%	0.1%	-
AMZNAmazon Com	$2.25T	29.3	0%	0.1%	vs AMZN

Davita Inc Company Information

Headquarters: Colorado; U.S.A
Website: www.davita.com
Sector: Health Care
Industry: Health Care Providers & Services

DVA - Davita Inc

About Davita Inc

DVA Key Statistics

How DVA Compares to Peers

Davita Inc Company Information

DVA Lician Score

DVA Financial Snowflake

Upcoming Events for DVA